ArticleExploratory research in clinical and social pharmacy2026
Clinical pharmacists' aspirations on prescribing in cardiology within an academic health system.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pharmacist prescribing in cardiology is influenced by clinical expertise, organizational structures, and expanding scopes of practice. Although international models highlight the value of pharmacist prescribers, limited evidence describes how prescribing is experienced within cardiology pharmacy practice. This study examined the prescribing potential, contextual conditions, and motivations of clinical pharmacists as part of continuing professional development. Methods: An interview-based qualitative design informed by collective autoethnography was used to situate researchers' professional experiences and reflections. Data were derived from retrospective reflections of clinical pharmacists and a pharmacy student working within an academic health system in the United Arab Emirates (UAE). Reflexive thematic analysis, guided by Braun and Clarke's six-phase approach, was conducted with iterative reflexivity and theoretical integration. Results: Twelve themes were generated from 155 coded excerpts and grouped into three domains: what pharmacists do when prescribing, when prescribing occurs, and why prescribing is undertaken. Prescribing activities included patient assessment, dose adjustment, and initiation of evidence-based cardiovascular therapies. Key enabling conditions were specialized training, interprofessional trust, and collaborative care structures. Motivations centered on enhancing autonomy, improving timely medication optimization, and achieving meaningful patient outcomes. Conclusion: Pharmacist prescribing in cardiology is a clinically grounded and collaborative practice that suggests potential to support timely therapeutic decisions and reduces treatment inertia. Insights from this insider perspective underscore the need for structured prescribing pathways, advanced training, and supportive regulatory frameworks to enable pharmacists to practice at their full scope.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.